c. Lepsza niż u osób zdrowych

7. Do mechanizmów korzystnego działania szczepienia przeciw grypie należą:

a. Zmniejszenie ryzyka rozwoju zapalenia w blaszkach miażdżycowych

b. Poprawa czynności fagocytarnej makrofagów

c. Zwiększenie stężenia cholesterolu HDL

8. W Polsce, w grupie osób w wieku ≥65 lat zapobiegawczo szczepi się przeciw infekcjom grypowym każdego roku:

a. 16% osób

b. 36% osób

c. 56% osób

9. Wykazano, że poprawie wyrównania metabolicznego u chorych na cukrzycę towarzyszy:

a. Zmniejszenie ryzyka zgonu z powodu infekcji

b. Zmniejszenie ryzyka zgonu z przyczyn sercowo-naczyniowych

c. Prawidłowa odpowiedź a i b

10. Szczepienia przeciw wirusom grypy istotnie zmniejszają ryzyko hospitalizacji u chorych na cukrzycę

a. Zdanie prawdziwe

b. Zdanie fałszywe

c. Obecnie nie ma na rynku szczepionek przeciw grypie

Piśmiennictwo:

1. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2009. Diabetologia Doświadczalna i Kliniczna 2009,suppA, A 42.

2. World Health Organization. Weekly Epidemiological Record. Pneumococcal vaccines No. 14, 2003;78:97-120.

3. Jokinen C, Heiskanen L, Juvonen H. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis 2001;32:1141-1154.

4. Fedson DS, Musher D. Pneumococcal polysaccharide vaccine. In: Plotkin A, Orenstein WA editors. Vaccines. 4th ed. Philadelphia, USA: WB Saunders Company 2004:529-588.

5. Pneumococcal. In: The green book chapter 25. Immunization against infectious disease. London, United Kingdom Department of Health 2006.

6. Musher DM. Streptococcus pneumoniae. In: Mandell G, Bennett JE, Dolin R editors. Principles and practice of infectious disease. 4th ed. New-York, USA: Churchill Livingstone, Inc. 1995:1811-1826.

7. American Diabetes Association. Flu & Pneumonia shots. [Online] 2007; [1 page] Available from: URL http://diabetes.org/gestational-diabetes/flu-pneumonia-shots.jsp

8. CDC. Recommendations of the ACIP. Prevention of pneumococcal disease. MMWR 1997;46:1-2.

9. Mizock BA. Alternations in fuel metabolism in critical illness: hyperglycemia. Best Pract Clin Endocrinol Metab, 2001;15:533-551.

10. The ESICM Working Group: Metabolic basis of nutrition in intensive care unit patients: ten critical questions. Intensive Care Med 2002;28:1512-1520.

11. The UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.

12. Khaodhair L, McCowen K, Bistrian B. Perioperative hyperglycemia, infection or risk. Curr Opin Clin Nutr Metab Care 1999;2:79-82.

13. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.

14. Pomposelli JJ, Baxter JK, Babineau TJ. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr 1998;22:77-81.

15. Guvener M, Pasaoglu I, Demircin M, et al. Peroperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002;49:531-537.

16. Van den Berghe G., Wouters P., Weekers F. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.

17. Douvin C, Simon D, Charles MA, et al. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen. Diabetes Care 1997;20:148-151.

18. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000;23:95-108.

19. Community Health Behavior Survey 2001. Influenza and pneumonia immunization, 2001:25-30.

20. Butler SO, Btaiche IF, Alaniz C. Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy 2005;25:963-976.

21. Smith SA, Poland GA. Use of influenza and pneumococcaI vaccines in people with diabetes. Diabetes Care 2000;23:95-108.

22. El-Reshaid K, Al-Mufti S, Johny KV, et al. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 1994;12:223-228.

23. El-Madhun AS, Cox RJ, Seime A, et al. Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study. Vaccine 1998,2/3:156-160.

24. Van Den Akker IL, Verheij TJM., Buskens E, et al. Clinical effectiveness of first and repeat influenza vaccination in adults and elderly diabetic patients. Diabetes Care 2006;29:1771-1776.

25. Colquhoun A. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes, Epidemiology and Infection 1997;119:335-341.

26. Bond TC, Patel PR, Krisher J, et al. Association of standing-order policies with vaccination rates in dialysis clinics: a US-Based Cross-sectional Study. Am J Kidney Dis 2009;54:86-94.

27. Gilbertson DT, Unruh M, McBean AM, et al. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 2003;63:738-743.

28. Vogtlander NPJ, Brown A., Valentijn RM, et al. Impaired response rates, but satisfying rates to influenza vaccination in dialysis patients. Vaccine 2004;22:2199-2201.

29. Scharpe J, Peetermans WE, Vanwalleghem J,et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. American Journal of Kidney Disease 2009;54:77-85.

30. Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: a Prospective Cohort Study. Am J Kidney Dis 2009;54:112-121.

31. Brydak LB, Roszkowska-Blaim M, Machala M, et al. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 2000;18:3280-3286.

32. Fuchshuber A, Kuhnemund O, Keuth B, et al. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996;11:468-473.

33. Vieira S, Baldacci ER, Carneiro-Sampaio M, et al. Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease. Pediatr Nephrol. 2009;24:83-89.

34. Pourfarziani V, Ramezani MB, Taheri S, et al. Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial. Ann Transplant 2008;13:43-47.

Do góry